Amalgamated Bank’s Regeneron Pharmaceuticals Position
Does Amalgamated Bank own Regeneron Pharmaceuticals (REGN)? Yes — 18.7K shares worth $14M (+0.11% of its 13F portfolio) as of Q1 2026, down from 19.3K shares the prior filed quarter.
Position Value
$14M
Q1 2026
Shares
18.7K
% of Portfolio
+0.11%
Quarters Held
29
currently held
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 18.7K | $14M | +0.11% |
| Q4 2025 | 19.3K | $15M | +0.11% |
| Q3 2025 | 19.4K | $11M | +0.08% |
| Q2 2025 | 20.1K | $11M | +0.08% |
| Q1 2025 | 20.6K | $13M | +0.11% |
| Q4 2024 | 20.4K | $15M | +0.12% |
| Q3 2024 | 22.8K | $24M | +0.20% |
| Q2 2024 | 21.4K | $23M | +0.19% |
| Q1 2024 | 21.7K | $21M | +0.18% |
| Q4 2023 | 25.9K | $23M | +0.18% |
| Q3 2023 | 27.0K | $22M | +0.19% |
| Q2 2023 | 27.7K | $20M | +0.16% |
| Q1 2023 | 30.7K | $25M | +0.22% |
| Q4 2022 | 27.8K | $20M | +0.18% |
| Q3 2022 | 29.8K | $21M | +0.20% |
| Q2 2022 | 28.2K | $17M | +0.16% |
| Q1 2022 | 27.8K | $19M | +0.15% |
| Q4 2021 | 29.2K | $18M | +0.14% |
| Q3 2021 | 27.4K | $17M | +0.14% |
| Q2 2021 | 28.5K | $16M | +0.13% |
| Q1 2021 | 6.0K | $3M | +0.11% |
| Q4 2020 | 6.3K | $3M | +0.12% |
| Q3 2020 | 6.4K | $4M | +0.15% |
| Q2 2020 | 6.5K | $4M | +0.19% |
| Q1 2020 | 12.2K | $6M | +0.15% |
| Q4 2019 | 12.7K | $5M | +0.09% |
| Q3 2019 | 12.0K | $3M | +0.07% |
| Q2 2019 | 11.5K | $4M | +0.08% |
| Q1 2019 | 12.1K | $5M | +0.12% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amalgamated Bank’s full portfolio or all institutional holders of REGN.